Home/Filings/4/0001209191-16-119690
4//SEC Filing

Insys Therapeutics, Inc. 4

Accession 0001209191-16-119690

CIK 0001516479operating

Filed

May 11, 8:00 PM ET

Accepted

May 12, 7:06 PM ET

Size

10.5 KB

Accession

0001209191-16-119690

Insider Transaction Report

Form 4
Period: 2016-05-11
Transactions
  • Purchase

    Common Stock

    2016-05-11$12.94/sh+40,000$517,70842,414,610 total(indirect: By Trust)
  • Purchase

    Common Stock

    2016-05-12$12.41/sh+10,000$124,11942,424,610 total(indirect: By Trust)
Holdings
  • Common Stock

    31,982
  • Common Stock

    (indirect: By Partnership)
    56,288
KAPOOR JOHN N
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2016-05-11$12.94/sh+40,000$517,70842,414,610 total(indirect: By Trust)
  • Purchase

    Common Stock

    2016-05-12$12.41/sh+10,000$124,11942,424,610 total(indirect: By Trust)
Holdings
  • Common Stock

    31,982
  • Common Stock

    (indirect: By Partnership)
    56,288
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.68 to $13.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  • [F2]By The John N. Kapoor Trust dated September 20, 1989.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.32 to $12.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  • [F4]By EJ Financial/NEO Management, L.P. of which the reporting person is Managing General Partner.

Issuer

Insys Therapeutics, Inc.

CIK 0001516479

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001516479

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 7:06 PM ET
Size
10.5 KB